Treatment of fibromyalgia with tropisetron, a 5HT3 serotonin antagonist: A pilot study

Clinical Rheumatology

Volumn 19, Issue 1, 2000, Pages 6-8

  Papadopoulos, I A ^a   Georgiou, P E ^a   Katsimbri, P P ^a   Drosos, Alexandros A ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

Author keywords

Fibromyalgia; Serotonin antagonist; Tropisetron

Indexed keywords

SEROTONIN 3 ANTAGONIST; SEROTONIN DERIVATIVE; SUBSTANCE P; TROPISETRON;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FATIGUE; FEMALE; FIBROMYALGIA; HUMAN; MYALGIA; PAIN ASSESSMENT; PILOT STUDY; PRIORITY JOURNAL; SLEEP DISORDER; TREATMENT OUTCOME;

ADULT; FEMALE; FIBROMYALGIA; HUMANS; INDOLES; MIDDLE AGED; PAIN MEASUREMENT; PILOT PROJECTS; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT3; SEROTONIN ANTAGONISTS; TREATMENT OUTCOME;

EID: 0034006584     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s100670050002     Document Type: Article

References (11)

1. Goldenberg DL, Fibromyalgia. In: Klippel JM, Dieppe PA, editors. Rheumatology. St Louis: Mosby, 1994:5.16.1-5.16.12.
2. Yunus MB, Masi AT, Calabro JJ, Miller KA, Feigenbaum SL. Primary fibromyalgia (fibrositis): clinical study of 50 patients with matched normal controls. Semin Arthritis Rheum 1981;11:151-71.
3. Wolfe F, Smythe HA, Yunus MB, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the multicentre criteria committee. Arthritis Rheum 1990;33:160-72.
4. Hudson JI, Goldenberg DL, Pope HG Jr, Keck PE, Schlessinger L. Comorbidity of fibromyalgia with medical and psychiatric disorders. Am J Med 1992;92:363-7.
5. Morris R, Sharpe M, Sharplay AL, Cowen PJ, Hawton K, Morris J. Abnormalities of sleep in patients with chronic fatique syndrome. Br Med J 1993;306:1161.
6. Wolfe F, Russell IJ, Vipraio G, Ross K, Anderson J. Serotonin levels, pain threshold, and fibromyalgia symptoms in the general population. J Rheumatol 1997;24:555-9.
7. Moldofsky H. Sleep and fibrositis syndrome. Rheum Dis Clin North Am 1989;15:91-103.
8. Vaeroy H, Helle R, Forre Ø, Kass E, Terenius L. Elevated CSF levels of substance P and high incidence of Raynaud's phenomenon in patients with fibromyalgia: new features for diagnosis. Pain 1988;32:21-6.
9. Rusell IJ, Orr MD, Littman B, et al. Elevated cerebrospinal fluid levels of substance P in patients with the fibromyalgia syndrome. Arthritis Rheum 1994;37:1593-1601.
10. Karel M de Bruijn. Tropisetron. A review of the clinical experience. Drugs 1992;43(suppl 3): 11-22.
11. 3-Rezeptoren. Z fur Rheumatologie 1994;53:335-8.